Home > Cashflow Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
WINDLAS BIOTECH is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹68 Cr₹109 Cr₹61 Cr₹9.13 Cr₹11 Cr

What is the latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH ?

The latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH is ₹68 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹68 Cr
Mar2024₹109 Cr
Mar2023₹61 Cr
Mar2022₹9.13 Cr
Mar2021₹11 Cr

How is Cash Flow from Operating Activities of WINDLAS BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹68 Cr
-37.42
Mar2024 ₹109 Cr
78.73
Mar2023 ₹61 Cr
567.74
Mar2022 ₹9.13 Cr
-20.30
Mar2021 ₹11 Cr -

Compare Cash Flow from Operating Activities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,800.8 Cr 0.1% 8.7% -14.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

0.1%

8.7%

-14.3%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses